ADOCIA: Information relating to the number of shares and voting rights as of March 31, 2024
6 p.m. CEST – In accordance with the provisions of article L.233-8 II of the Commercial Code and article 223-16 of the General Regulations of the Financial Markets Authority (“AMF”). ADOCIA SA, 115, avenue Lacassagne, 69003 Lyon (Euronext Paris: FR0011184241 – ADOC – the “Company”), clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity publishes the number of shares making up its share capital as well as the number of associated voting rights as of March 31, 2024.